Clinical trial
A Study of Beta-Lactam in Hospitalized Patients With Skin and Skin Structure…
NCT00303589 · Hoffmann-La Roche, Industry · Completed
Key facts
| NCT number | NCT00303589 |
|---|---|
| Title | A Study of Beta-Lactam in Hospitalized Patients With Skin and Skin Structure Infections |
| Official title | A Phase II Prospective, Open Label, Randomized, Active-controlled, Parallel Group, Multi-center 'Proof of Concept' Trial in Adult Patients With Complicated Skin or Skin Structure Infections Requiring Hospitalization. |
| Lead sponsor | Hoffmann-La Roche, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Soft Tissue Infections |
| Intervention type | Drug |
| Interventions | Standard care, beta-lactam |
| Enrollment | 313 |
| Start date | Dec 1, 2005 |
| Primary completion | Oct 1, 2007 |
| Completion | Oct 1, 2007 |
| First posted | Mar 17, 2006 |
| Last update posted | Nov 2, 2016 |
| Countries | Argentina, Bulgaria, Estonia, Germany, Hungary, Latvia, Lithuania, Peru, Romania, South Africa, United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: